Balderton Capital led the Series A round with participation from Amadeus Capital Partners and Jonathan Milner.
"Healx has a simple but profound goal: To transform the lives of rare disease patients. Our technology helps us find treatments where none currently exist,"
The investment from Henley Business Angels members will support international scale-up and team expansion.
"We are delighted to have backing from the Henley Business Angels as we continue the international scale-up of our OBRIZUM cloud platform. OBRIZUM uses deep proprietary Artificial Intelligence technology to personalise know-how transfer and business intelligence analytics and the backing from Henley Business Angels will support us in adding to our growing team of software engineers and data scientists, so that we can continue to build world class enterprise software."